- Raised $1M funding round
About
Deliverance has established core proprietary technologies that provide solutions for the immediate management and control of bleeding, hemorrhage, and shock due to blood vessel perforations that can occur during minimally invasive surgeries, open and vascular surgeries, andas a result of trauma. The companys Lap Braided S&F Catheter isdesigned for use in emergency situations caused by severe bleeding during minimally invasive surgeries. The device has a thin profile and flexible distal portion that permits rapid sealing of perforations of various sizes and at different locations inthe major blood vessel system of the abdomen and thorax. The Open Surgery and Field S&F Catheter uses proprietary technology that allows complete and rapid sealing of perforations with a dual blockade. Specially designed sealing cushions discretely block the perforation from inside and outside the vessel wall. The device also provides an option to keep an open line to the injured vessel, allowing liquid transfusion with flow rates greater than 500 milliliters per minute to efficiently treat possible hypovolemia.
Funding history · 1 round · $1.0M total
Q&A
- What is Deliverance's primary focus?
- Deliverance focuses on developing proprietary technologies for the immediate management and control of bleeding, hemorrhage, and shock resulting from blood vessel perforations during surgeries or trauma.
- What is the status of Deliverance?
- Deliverance is currently inactive, as of December 2017.
- Where is Deliverance headquartered?
- Deliverance is headquartered in Qatsrin, North District, Israel.
- What is Deliverance's Lap Braided S&F Catheter designed for?
- The Lap Braided S&F Catheter is designed for emergency situations involving severe bleeding during minimally invasive surgeries, allowing rapid sealing of perforations in major blood vessels.
- How does Deliverance's Open Surgery and Field S&F Catheter work?
- The Open Surgery and Field S&F Catheter uses proprietary technology for complete and rapid sealing of perforations with a dual blockade, using sealing cushions to block the perforation from both inside and outside the vessel wall. It also allows for liquid transfusion.
- When was Deliverance founded?
- Deliverance was founded in March 2009.
- How much funding has Deliverance raised in total?
- Deliverance has raised a total of $1,000,000 USD.
- What is Deliverance's employee count?
- Deliverance has an employee count in the 11-50 range.
- Who are the co-founders of Deliverance?
- The co-founders of Deliverance are Ehud Almon and Dan Aravot.
Team · 2
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 2009-3 |
|---|---|
| Employees (exact) | 31 |
| Status reason | Non Active, Dec 2017 |